The present invention relates to carrier-linked prostanoid prodrugs of formula (I) Z1 -(X0 - L0 - PG0)y (I), wherein Z1, X0, L0, PG0 and y have the meaning as indicated in the description and claims; pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising the same. It further relates to their use as medicaments, especially for treating, controlling, delaying or preventing pulmonary arterial hypertension.
本发明涉及式(I)的载体连结
前列腺素前药,其中Z1,X0,L0,
PG0和y的含义如说明和权利要求中所示;其药学上可接受的盐和包含它们的制药组合物。它还涉及它们作为药物的用途,特别是用于治疗、控制、延迟或预防肺动脉高压。